Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Noble

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Organic Process Research & Development|December 27, 2021
Toward a Practical, Nonenzymatic Process for Investigational COVID-19 Antiviral Molnupiravir from Cytidine: Supply-Centered SynthesisVijayagopal Gopalsamuthiram, Appasaheb L Kadam, Jeffrey K Noble, et al.
Medrxiv : the Preprint Server for Health Sciences|October 4, 2023
Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022Kelsey M Sumner, Ruchi Yadav, Emma K Noble, et al.
The Journal of Infectious Diseases|July 25, 2024
Anti-SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021-June 2022Kelsey M Sumner, Ruchi Yadav, Emma K Noble, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2023
Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021-June 2022Ryan Sandford, Ruchi Yadav, Emma K Noble, et al.
Influenza and Other Respiratory Viruses|July 16, 2024
Antibody Response to Symptomatic Infection With SARS-CoV-2 Omicron Variant Viruses, December 2021-June 2022Ryan Sandford, Ruchi Yadav, Emma K Noble, et al.
The Journal of Infectious Diseases|December 2, 2025
Improved immune response against influenza A viruses with receipt of a recombinant influenza vaccine in healthcare personnel with prior low antibody response to egg-based influenza vaccines, Israel, 2019-20Kelsey M Sumner, Mark Katz, Avital Hirsch, et al.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Influenza Antibody Levels Associated with Laboratory-Confirmed Influenza in a Test-Negative Study Design, US Flu VE Network, November 2018-May 2019Brendan Flannery, Jessie R Chung, Crystal Holiday, et al.
Pediatrics|January 8, 2026
Influenza Vaccine Effectiveness Among Children With and Without Underlying ConditionsHaya Hayek, Emma K Noble, Laura S Stewart, et al.
MMWR. Morbidity and Mortality Weekly Report|February 13, 2025
Notes from the Field: Seroprevalence of Highly Pathogenic Avian Influenza A(H5) Virus Infections Among Bovine Veterinary Practitioners - United States, September 2024Jerome Leonard, Elizabeth J Harker, Christine M Szablewski, et al.
JAMA Network Open|December 27, 2024
Estimated Vaccine Effectiveness for Pediatric Patients With Severe Influenza, 2015-2020Kelsey M Sumner, Leila C Sahni, Julie A Boom, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Organic Process Research & Development|December 27, 2021
Toward a Practical, Nonenzymatic Process for Investigational COVID-19 Antiviral Molnupiravir from Cytidine: Supply-Centered SynthesisVijayagopal Gopalsamuthiram, Appasaheb L Kadam, Jeffrey K Noble, et al.
Medrxiv : the Preprint Server for Health Sciences|October 4, 2023
Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022Kelsey M Sumner, Ruchi Yadav, Emma K Noble, et al.
The Journal of Infectious Diseases|July 25, 2024
Anti-SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021-June 2022Kelsey M Sumner, Ruchi Yadav, Emma K Noble, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2023
Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021-June 2022Ryan Sandford, Ruchi Yadav, Emma K Noble, et al.
Influenza and Other Respiratory Viruses|July 16, 2024
Antibody Response to Symptomatic Infection With SARS-CoV-2 Omicron Variant Viruses, December 2021-June 2022Ryan Sandford, Ruchi Yadav, Emma K Noble, et al.
The Journal of Infectious Diseases|December 2, 2025
Improved immune response against influenza A viruses with receipt of a recombinant influenza vaccine in healthcare personnel with prior low antibody response to egg-based influenza vaccines, Israel, 2019-20Kelsey M Sumner, Mark Katz, Avital Hirsch, et al.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Influenza Antibody Levels Associated with Laboratory-Confirmed Influenza in a Test-Negative Study Design, US Flu VE Network, November 2018-May 2019Brendan Flannery, Jessie R Chung, Crystal Holiday, et al.
Pediatrics|January 8, 2026
Influenza Vaccine Effectiveness Among Children With and Without Underlying ConditionsHaya Hayek, Emma K Noble, Laura S Stewart, et al.
MMWR. Morbidity and Mortality Weekly Report|February 13, 2025
Notes from the Field: Seroprevalence of Highly Pathogenic Avian Influenza A(H5) Virus Infections Among Bovine Veterinary Practitioners - United States, September 2024Jerome Leonard, Elizabeth J Harker, Christine M Szablewski, et al.
JAMA Network Open|December 27, 2024
Estimated Vaccine Effectiveness for Pediatric Patients With Severe Influenza, 2015-2020Kelsey M Sumner, Leila C Sahni, Julie A Boom, et al.
Pageof 8